Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Daniel Geoffrey Tenen, M.D.

Concepts (986)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Daniel Tenen's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Daniel Tenen has written about over time.
DNA-Binding Proteins, 41 publications between 1985 and 2021, average publication date June 2000. Antigens, CD34, 23 publications between 1990 and 2012, average publication date March 2001. Promoter Regions, Genetic, 75 publications between 1981 and 2021, average publication date October 2002. Leukemia, Myeloid, 23 publications between 1992 and 2020, average publication date July 2004. Transcription Factors, 68 publications between 1994 and 2021, average publication date January 2005. Granulocytes, 46 publications between 1989 and 2020, average publication date February 2005. Gene Expression Regulation, 56 publications between 1990 and 2021, average publication date February 2005. Proto-Oncogene Proteins, 63 publications between 1994 and 2021, average publication date October 2005. Hematopoietic Stem Cells, 71 publications between 1989 and 2021, average publication date June 2006. Core Binding Factor Alpha 2 Subunit, 30 publications between 1994 and 2021, average publication date July 2006. CCAAT-Enhancer-Binding Proteins, 31 publications between 1995 and 2021, average publication date August 2006. Cell Differentiation, 98 publications between 1989 and 2021, average publication date September 2006. Hematopoiesis, 50 publications between 1994 and 2021, average publication date September 2006. Trans-Activators, 50 publications between 1995 and 2021, average publication date May 2007. CCAAT-Enhancer-Binding Protein-alpha, 54 publications between 2001 and 2019, average publication date December 2007. Oncogene Proteins, Fusion, 22 publications between 2000 and 2021, average publication date March 2009. Myeloid Cells, 19 publications between 2001 and 2021, average publication date December 2009. Leukemia, Myelogenous, Chronic, BCR-ABL Positive, 12 publications between 1996 and 2021, average publication date April 2011. Leukemia, Myeloid, Acute, 48 publications between 1996 and 2021, average publication date June 2011. Gene Expression Regulation, Leukemic, 28 publications between 2000 and 2021, average publication date September 2012.

To see the data from this visualization as text, click here.
Tenen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (986)
Explore
_
Co-Authors (112)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.